Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France”

Detalles Bibliográficos
Autores principales: Bonny, Aimé, Talle, Mohammed A., Ngantcha, Marcus, Tayebjee, Muzahir H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462460/
https://www.ncbi.nlm.nih.gov/pubmed/32889105
http://dx.doi.org/10.1016/j.tmaid.2020.101861
_version_ 1783576920795906048
author Bonny, Aimé
Talle, Mohammed A.
Ngantcha, Marcus
Tayebjee, Muzahir H.
author_facet Bonny, Aimé
Talle, Mohammed A.
Ngantcha, Marcus
Tayebjee, Muzahir H.
author_sort Bonny, Aimé
collection PubMed
description
format Online
Article
Text
id pubmed-7462460
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-74624602020-09-02 Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France” Bonny, Aimé Talle, Mohammed A. Ngantcha, Marcus Tayebjee, Muzahir H. Travel Med Infect Dis Correspondence Elsevier Ltd. 2020 2020-09-01 /pmc/articles/PMC7462460/ /pubmed/32889105 http://dx.doi.org/10.1016/j.tmaid.2020.101861 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Bonny, Aimé
Talle, Mohammed A.
Ngantcha, Marcus
Tayebjee, Muzahir H.
Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France”
title Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France”
title_full Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France”
title_fullStr Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France”
title_full_unstemmed Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France”
title_short Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France”
title_sort conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of covid-19. comment on “early treatment of covid-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in marseille, france”
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462460/
https://www.ncbi.nlm.nih.gov/pubmed/32889105
http://dx.doi.org/10.1016/j.tmaid.2020.101861
work_keys_str_mv AT bonnyaime conflictingevidenceontheefficacyofhydroxychloroquineandazithromycinastheearlytreatmentofcovid19commentonearlytreatmentofcovid19patientswithhydroxychloroquineandazithromycinaretrospectiveanalysisof1061casesinmarseillefrance
AT tallemohammeda conflictingevidenceontheefficacyofhydroxychloroquineandazithromycinastheearlytreatmentofcovid19commentonearlytreatmentofcovid19patientswithhydroxychloroquineandazithromycinaretrospectiveanalysisof1061casesinmarseillefrance
AT ngantchamarcus conflictingevidenceontheefficacyofhydroxychloroquineandazithromycinastheearlytreatmentofcovid19commentonearlytreatmentofcovid19patientswithhydroxychloroquineandazithromycinaretrospectiveanalysisof1061casesinmarseillefrance
AT tayebjeemuzahirh conflictingevidenceontheefficacyofhydroxychloroquineandazithromycinastheearlytreatmentofcovid19commentonearlytreatmentofcovid19patientswithhydroxychloroquineandazithromycinaretrospectiveanalysisof1061casesinmarseillefrance

Ejemplares similares